Want to see GL full AI Analyst Report?
GL Stock Chart & Stats
$175.55
$0.02(0.01%)
At close: 4:00 PM EDT
$175.55
$0.02(0.01%)
Day’s Range― - ―
52-Week Range$127.85 - $191.55
Previous CloseN/A
Volume190.64K
Average Volume (3M)428.98K
Market Cap
$13.04B
Enterprise Value$17.04B
Total Cash (Recent Filing)$455.38M
Total Debt (Recent Filing)$2.94B
Price to Earnings (P/E)11.1
Beta0.46
Next Earnings
Feb 10, 2027EPS Estimate
3.79Next Dividend Ex-DateN/A
Dividend Yield0.74%
Share Statistics
EPS (TTM)15.22
Shares Outstanding76,849,450
10 Day Avg. Volume403,052
30 Day Avg. Volume428,977
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.89
Price to Sales (P/S)1.89
P/FCF Ratio9.02
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue2.75
Enterprise Value/Gross Profit16.18
Enterprise Value/Ebitda27.01
Forecast
1Y Price Target
$196.88Price Target Upside12.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)15.73
Revenue Forecast (FY)$6.40B
Bulls Say, Bears Say
Bulls Say
Steady Revenue And Earnings GrowthGlobe Life has demonstrated durable operating momentum, with revenue and net income rising across the reported periods. Continued premium growth and resilient profitability provide a foundation for reinvestment, capital returns, and sustained earnings power over the next several quarters.
Strong Cash GenerationHigh free-cash-flow conversion indicates that reported earnings are supported by substantial cash generation. This gives Globe Life flexibility to fund operations, absorb claim variability, support investment needs, and return capital without relying solely on external financing.
Conservative Investment PortfolioA predominantly high-quality investment portfolio supports the recurring investment-income component of Globe Life’s insurance model. Strong asset quality can help protect capital and earnings resilience while the company earns approximately 5.5% on long-term invested assets.
Bears Say
Health Claims And Margin VolatilityHigher health obligations and several adverse claims adjustments have weakened underwriting margins and increased earnings volatility. If elevated claims persist, Globe Life may face pressure on segment profitability, pricing assumptions, and the consistency of consolidated operating results.
Direct-to-consumer Distribution DisruptionThe disruption to paid search affects a direct customer-acquisition channel and may require Globe Life to redesign content, advertising, and conversion strategies. A prolonged transition could constrain DTC growth and increase marketing inefficiency before replacement methods reach scale.
EVRI Startup LossesEVRI is currently dilutive to United American’s health economics, showing that new-product expansion carries execution and claims risk before scale benefits emerge. Further losses or slower growth could weigh on health margins and offset otherwise strong premium expansion.
Globe Life News
GL FAQ
What was Globe Life’s price range in the past 12 months?
Globe Life lowest stock price was $127.84 and its highest was $191.55 in the past 12 months.
What is Globe Life’s market cap?
Globe Life’s market cap is $13.04B.
When is Globe Life’s upcoming earnings report date?
Globe Life’s upcoming earnings report date is Feb 10, 2027 which is in 111 days.
How were Globe Life’s earnings last quarter?
Globe Life released its earnings results on Oct 21, 2026. The company reported $4.84 earnings per share for the quarter, missing the consensus estimate of $4.904 by -$0.064.
Is Globe Life overvalued?
According to Wall Street analysts Globe Life’s price is currently Undervalued.
Does Globe Life pay dividends?
Globe Life pays a Quarterly dividend of $0.33 which represents an annual dividend yield of 0.74%. See more information on Globe Life dividends here
What is Globe Life’s EPS estimate?
Globe Life’s EPS estimate is 3.79.
How many shares outstanding does Globe Life have?
Globe Life has 76,849,450 shares outstanding.
What happened to Globe Life’s price movement after its last earnings report?
Globe Life reported an EPS of $4.84 in its last earnings report, missing expectations of $4.904. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Globe Life?
Currently, no hedge funds are holding shares in GL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globe Life Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$196.88 (12.15% Upside)
$196.88 (12.15% Upside)
Blogger Sentiment
Neutral
GL Sentiment 83%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Decreased
By 28.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $30.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.73%
12-Months-Change
Fundamentals
Return on Equity
19.84%
Trailing 12-Months
Asset Growth
―
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Globe Life
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
GL Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong positives — double-digit GAAP and operating EPS growth, premium growth (especially in health and United American), improving investment yields and conservative portfolio positioning, an expanded share repurchase program, and upward guidance aided by expected assumption-update benefits. Counterbalancing these are execution and margin pressures: DTC sales disruption from AI-driven changes in search, a YoY decline in AIL agent count (though with sequential improvement), elevated health claims and higher health obligation ratios in Q2, and a near-term drag from the EVRI startup. Investment unrealized losses are interest-rate driven and manageable per management. On balance the company emphasized resilient operations, conservative investments, returning capital to shareholders, and clear plans to address distribution and AI-related digital changes.View all GL earnings summariesGL Revenue Breakdown
56.44% Life
24.31% Health
0.00% Annuity
19.65% Investment
<0.01% Corporate & Other
-0.42% Realized gains (losses)
GL Stock 12 Month Forecast
Average Price Target
$196.88
▲(12.15% Upside)
Technical Analysis
Ownership Overview
0.72% Insiders
25.03% Mutual Funds
0.67% Other Institutional Investors
44.66% Public Companies and
Individual Investors